Free tool
Diagnostics stocks
We cover 9 companies grouped under the Diagnostics theme. The median market value in the group is $7.58B. Across the group, the median move over the past trading day is +0.31%. Price change over the past year runs from −21.7% to +237.1% across the middle 80 percent of the group, with a median of +38.1%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
9 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| NTRA | Natera, Inc. | $338.45 | +34.19% | +47.90% | +107.59% | Nov 5, 2026 |
| 0KSX.L | Quest Diagnostics Incorporated | $244.75 | +0.90% | +43.04% | +39.19% | Oct 20, 2026 |
| LH | Labcorp Holdings Inc. | $335.72 | +6.84% | +33.74% | +21.14% | Nov 3, 2026 |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% | Oct 20, 2026 |
| CAI | Caris Life Sciences, Inc. | $26.82 | +72.03% | −0.59% | −29.83% | Nov 4, 2026 |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% | Nov 3, 2026 |
| BDSX | Biodesix, Inc. | $30.60 | +45.51% | +373.68% | +225.53% | Nov 3, 2026 |
| 0RAR.L | Stratec SE | 22.90 EUR | +2.00% | +3.39% | −14.98% | Nov 12, 2026 |
| XGN | Exagen Inc. | $7.67 | +72.36% | +26.99% | −19.69% | Nov 10, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.